A PROPENSITY SCORE-MATCHED COMPARISON OF INFLIXIMAB AND ADALIMUMAB IN NAïVE AND NON-NAïVE PATIENTS WITH CROHN'S DISEASE: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)
Ambrogio Orlando 1
Fabio Salvatore Macaluso 1
Walter Fries 2
Antonio Carlo Privitera 3
Maria Cappello 4
Sebastiano Siringo 5
Gaetano Inserra
Antonio Magnano
Roberto Di Mitri
Filippo Mocciaro
Nunzio Belluardo
Giuseppe Scarpulla
Giovanni Magri
Antonino Trovatello
Antonio Carroccio
Salvatore Genova
Carmelo Bertolami
Robe
1 IBD Unit, 'Villa Sofia-Cervello' Hospital,Palermo,Italy
2 Inflammatory bowel disease Unit, A.O.U. Policlinico,Messina,Italy
3 IBD Unit, A.O. 'Cannizzaro”, Catania, Italy.,Catania,Italy
4 Gastroenterology and Hepatology Unit, A.O.U. Policlinico “G. Giaccone”,Palermo,Italy
5 Gastroent
Conference
UEG Week 2018
Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]